Two Chinese reverse mergers, Tianyin Pharmaceutical Group, Inc. (AMEX: TPI) and JPAK Group, Inc. (OTC: JPAK), will not be able to file 10-Ks on time, according to SEC filings made by both companies on September […]
asensio.com previously reported that China Sky One Medical, Inc. (NASDAQ: CSKI) was the subject of an SEC investigation. The SEC investigation of CSKI has been ongoing since at least September 2009, when the SEC sent […]
Russell Investments dropped China Sky One Medical, Inc. (NASDAQ: CSKI) and other Chinese reverse mergers from its widely-followed Russell 3000 index this year. Other Chinese companies dropped by Russell include American Oriental Bioengineering, Inc. (NYSE: […]
Below are recent articles and reports concerning fraud in China, particularly surrounding US-listed Chinese companies, as well as recent press releases announcing class-action lawsuits or investigations against certain US-listed Chinese companies for suspected violations of […]
A report previously published by asensio.com raised concerns about a NASDAQ OMX Group, Inc. (NASDAQ: NDAQ) official in China having questionable involvement in Chinese reverse mergers. The report concerned Guangxun Xu, NASDAQ’s former chief representative […]
Barron’s published an article on August 26, 2010, titled “Beware This Chinese Export,” discussing an individual involved with China Green Agriculture, Inc. (NYSE: CGA) being connected to a convicted criminal, as well as other questionable […]
On September 7th, shares of China Sky One Medical, Inc. (NASDAQ: CSKI) closed at $6.67, down 31% from the prior day’s close. CSKI put out a press release at the close of the previous trading […]
The videos available on the links below aired August 19, 2010 on ABC’s Good Morning America, World News Tonight and Nightline, prominently featured misconduct at Apollo Group, Inc. (Nasdaq: APOL). Apollo spends over 20% of […]
asensio.com has researched a series of publicly traded companies that have been allowed to register shares of their common stock to traded on the U.S. stock exchanges but whose purported operations are based almost solely […]
On July 15, 2010 Inside Higher Ed published an article titled “Does the Messenger Matter?” The article notes that asensio.com’s founder, Manuel P. Asensio, is president of a nonprofit group formed in December 2009 “that […]
Investment Funds Stir Controversy Over Recruiting by For-Profit Colleges – ProPublica
Since April, a nonprofit group associated with another high-profile investor, Manuel P. Asensio, has written five letters criticizing the for-profit education industry and calling for tighter regulation to congressmen and regulators with jurisdiction over the […]
Investment Funds Stir Controversy Over Recruiting by For-Profit Colleges – ProPublica
Short sellers flag school stocks – Politico
[A] famed short seller Manuel P. Asensio’s new nonprofit group has written to Education Secretary Arne Duncan, asking him to investigate the business practices of a for-profit education company. … “Without the scam on the […]
A study released this past May by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) on fraudulent financial reporting by U.S. public companies, which examined financial statement fraud allegations investigated by the U.S. […]
Today China Sky One Medical, Inc. (NASDAQ: CSKI) reported fourth quarter and fiscal year 2009 earnings. asensio.com previously reported on a controversy surrounding CSKI’s patents – namely, that CSKI did not have any patents, though […]
Yesterday Yuhe International, Inc. (NASDAQ: YUII) announced that Grant Thornton “is resigning as the Company’s independent registered public accounting firm effective immediately,” according to an 8-K filed by Yuhe. Yuhe’s share-price fell 18% yesterday. Yuhe […]
Today asensio.com released a report on Yuhe International, Inc. (NASDAQ: YUII), showing that Yuhe’s auditor resigned abruptly, apparently due to Yuhe’s questionable related party transactions. On December 30, 2009, executives from Yuhe rang NASDAQ’s opening […]
A report issued by asensio.com yesterday revealed that Moore Stephens, P.C., the accounting firm that serves as auditor to China Sky One Medical, Inc. (NASDAQ: CSKI), is the subject of a lawsuit. The complaint against […]
A private investor has filed a lawsuit against the auditor of China Sky One Medical, Inc. (NASDAQ: CSKI), alleging “fraudulent misconduct” and violation of securities laws for failing to correct CSKI’s “materially false” financial statements. […]
Shares of China Sky One Medical, Inc. (Nasdaq: CSKI) are under pressure today which could be related to reports late last week from Asensio.com that eight products manufactured by the company appear in a Chinese […]
Eight products manufactured by China Sky One Medical, Inc. (NASDAQ: CSKI) appear in a Chinese government notice of “counterfeit drug products,” which states that pharmacies should “immediately stop the sale” of these products. The government […]
Today asensio.com released a report on China Sky One Medical, Inc. (NASDAQ: CSKI), titled “CSKI Products on Government List of ‘Counterfeit Drug Products,’ Pharmacies Ordered to Stop Selling.” As shown in the report, eight of […]
The home and “other premises” of Toshio Masuda, an early investor in China Sky One Medical, Inc. (NASDAQ: CSKI), were raided by Japanese police based on suspected violation of Japanese securities laws, according to an […]
On January 4th China Sky One Medical, Inc. (NASDAQ: CSKI) issued a press release stating that its stock listing had been moved to the NASDAQ Global Select Market. CSKI referred to the Global Select Market […]
On January 4th China Sky One Medical, Inc. (NASDAQ: CSKI) issued a press release stating that its stock listing had been moved to the NASDAQ Global Select Market. CSKI referred to the Global Select Market […]
Below is a link to an article titled “China Finds Huge Fraud by Officials” from today’s New York Times. The article stated that “Every year Beijing announces new anticorruption drives, new laws and new policies […]
Below is a link to an article titled “China Finds Huge Fraud by Officials” from today’s New York Times. The article stated that “Every year Beijing announces new anticorruption drives, new laws and new policies […]
A report issued today on Guangxun Xu states that Finchley International Investments sold shares of Bodisen Biotech, Inc. (OTC: BBCZ $0.24) worth more than $2 million. Bodisen was delisted after authorities discovered incomplete and improper […]
© Asensio.com. All rights reserved.